{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T21:45:20Z","timestamp":1764884720960,"version":"3.46.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.rgmxen.2025.10.001","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T22:07:15Z","timestamp":1760825235000},"page":"530-546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Survey of Latin American gastroenterologists, specialists in disorders of gut-brain interaction, on the diagnosis and treatment of irritable bowel syndrome in clinical practice"],"prefix":"10.1016","volume":"90","author":[{"given":"I.","family":"Hanna-Jairala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.A.","family":"Puentes-Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Madrid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Aguilar-Paiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Suazo-Barahona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Remes-Troche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Coss-Adame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Bustos-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gudi\u00f1o-Zayas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schmulson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.rgmxen.2025.10.001_bib0005","first-page":"00222","article-title":"Bowel disorders","volume":"S0016-5085","author":"Mearin","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14569","article-title":"Comparison of the epidemiology of disorders of gut-brain interaction in four Latin American countries: Results of The Rome Foundation Global Epidemiology Study","volume":"35","author":"Schmulson","year":"2023","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","article-title":"ACG clinical guideline: Management of irritable bowel syndrome","volume":"116","author":"Lacy","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0020","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1136\/gutjnl-2021-324598","article-title":"British Society of Gastroenterology guidelines on the management of irritable bowel syndrome","volume":"70","author":"Vasant","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.gastro.2022.04.017","article-title":"AGA clinical practice guideline on the pharmacological management of irritable bowel syndrome with diarrhea","volume":"163","author":"Lembo","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0030","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/j.gastro.2022.04.016","article-title":"AGA clinical practice guideline on the pharmacological management of irritable bowel syndrome with constipation","volume":"163","author":"Chang","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0035","first-page":"149","article-title":"The Mexican consensus on irritable bowel syndrome","volume":"81","author":"Carmona-S\u00e1nchez","year":"2016","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0040","article-title":"Tratamiento farmacol\u00f3gico del s\u00edndrome de intestino irritable en M\u00e9xico. Posicionamiento de la Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda 2024","author":"Remes-Troche","year":"2025","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0045","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/bmj.2.6138.653","article-title":"Towards positive diagnosis of the irritable bowel","volume":"2","author":"Manning","year":"1978","journal-title":"Br Med J"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0050","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/j.1572-0241.2000.03192.x","article-title":"A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome","volume":"95","author":"Saito","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0055","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1053\/j.gastro.2021.11.019","article-title":"Rome Foundation clinical diagnostic criteria for disorders of gut-brain interaction","volume":"162","author":"Drossman","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0060","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.2015.0954","article-title":"Irritable bowel syndrome: a clinical review","volume":"313","author":"Chey","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0065","article-title":"Fecal calprotectin and organic gastrointestinal disease: a systematic review","volume":"15","author":"Asiri","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0070","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","article-title":"Global prevalence of celiac disease: systematic review and meta-analysis","volume":"16","author":"Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0075","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0080","doi-asserted-by":"crossref","first-page":"458","DOI":"10.14309\/ajg.0000000000001122","article-title":"ACG clinical guidelines: Colorectal cancer screening 2021","volume":"116","author":"Shaukat","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.14309\/ajg.0000000000001548","article-title":"Updates on age to start and stop colorectal cancer screening: Recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer","volume":"117","author":"Patel","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0090","doi-asserted-by":"crossref","first-page":"208","DOI":"10.14309\/ajg.0000000000002130","article-title":"Management of patients with acute lower gastrointestinal bleeding: an updated ACG guideline","volume":"118","author":"Sengupta","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0095","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2050640620951905","article-title":"European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations","volume":"9","author":"Miehlke","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0105","article-title":"Appropriateness of CT scans for patients with non-traumatic acute abdominal pain","volume":"91","author":"de Burlet","year":"2018","journal-title":"Br J Radiol"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0110","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/gutjnl-2018-318081","article-title":"Assessment of Crohn\u2019s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review","volume":"68","author":"Bettenworth","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4329\/wjr.v10.i11.143","article-title":"Review of the role of abdominal imaging in irritable bowel syndrome","volume":"10","author":"Kavanagh","year":"2018","journal-title":"World J Radiol"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0120","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1053\/j.gastro.2016.02.009","article-title":"Functional anorectal disorders","volume":"150","author":"Rao","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.5056\/jnm16060","article-title":"Diagnosis and treatment of dyssynergic defecation","volume":"22","author":"Rao","year":"2016","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0130","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14335","article-title":"Review of the indications, methods, and clinical utility of anorectal manometry and the rectal balloon expulsion test","volume":"34","author":"Bharucha","year":"2022","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0135","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3389\/fpsyt.2020.00664","article-title":"Small intestinal bacterial overgrowth and irritable bowel syndrome - an update","volume":"11","author":"Takakura","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.14309\/ajg.0000000000000501","article-title":"ACG clinical guideline: Small intestinal bacterial overgrowth","volume":"115","author":"Pimentel","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12876-024-03230-x","article-title":"Fructose malabsorption and fructan malabsorption are associated in patients with irritable bowel syndrome","volume":"24","author":"Sia","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0150","first-page":"110","article-title":"The incidence of adult type hypolactasia in patients with irritable bowel syndrome","volume":"18","author":"Dom\u017ca\u0142-Magrowska","year":"2023","journal-title":"Prz Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0155","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.3390\/ijms25137341","article-title":"Identification of SIBO subtypes along with nutritional status and diet as key elements of SIBO therapy","volume":"25","author":"Wielgosz-Grochowska","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0160","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1159\/000528954","article-title":"Impact of Saccharomyces boulardii CNCM I-745 on bacterial overgrowth and composition of intestinal microbiota in diarrhea-predominant irritable bowel syndrome patients: results of a randomized pilot study","volume":"41","author":"Bustos-Fern\u00e1ndez","year":"2023","journal-title":"Dig Dis"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0165","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4067\/S0034-98872007001000003","article-title":"Sobrecrecimiento bacteriano en trastornos funcionales del intestino","volume":"135","author":"Madrid","year":"2007","journal-title":"Rev Med Chil"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0170","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s41395-018-0195-4","article-title":"A systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and a low FODMAPs diet in treating symptoms of irritable bowel syndrome","volume":"113","author":"Dionne","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0175","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jhn.12385","article-title":"British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update)","volume":"29","author":"McKenzie","year":"2016","journal-title":"J Hum Nutr Diet"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0180","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.757969","article-title":"Eluxadoline versus antispasmodics in the treatment of irritable bowel syndrome: an adjusted indirect treatment comparison meta-analysis","volume":"13","author":"Qin","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0185","doi-asserted-by":"crossref","DOI":"10.1177\/17562848211033740","article-title":"Efficacy of pinaverium bromide in the treatment of irritable bowel syndrome: a systematic review and meta-analysis","volume":"14","author":"Bor","year":"2021","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0190","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/MCG.0000000000001242","article-title":"Efficacy of the combination of pinaverium bromide 100 mg plus simethicone 300 mg in abdominal pain and bloating in irritable bowel syndrome: a randomized, placebo-controlled trial","volume":"54","author":"Schmulson","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0195","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.14309\/ajg.0000000000002800","article-title":"Central neuromodulators in irritable bowel syndrome: why, how, and when","volume":"119","author":"Hanna-Jairala","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0200","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2468-1253(19)30324-3","article-title":"Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis","volume":"5","author":"Black","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0205","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/abr.abr_247_20","article-title":"Investigation the effectiveness of duloxetine in quality of life and symptoms of patients with irritable bowel syndrome","volume":"10","author":"Salehian","year":"2021","journal-title":"Adv Biomed Res"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0210","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2017.11.279","article-title":"Neuromodulators for functional gastrointestinal disorders (disorders of gut-brain interaction): A Rome Foundation working team report","volume":"154","author":"Drossman","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0215","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11894-018-0664-3","article-title":"Psychotropics, antidepressants, and visceral analgesics in functional gastrointestinal disorders","volume":"20","author":"T\u00f6rnblom","year":"2018","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0220","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-230X-9-15","article-title":"A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome","volume":"9","author":"Hoveyda","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0225","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/j.gastro.2023.07.018","article-title":"Efficacy of probiotics in irritable bowel syndrome: systematic review and meta-analysis","volume":"165","author":"Goodoory","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0230","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.clinthera.2023.01.010","article-title":"Rifaximin treatment for individual and multiple symptoms of irritable bowel syndrome with diarrhea: an analysis using new end points","volume":"45","author":"Lacy","year":"2023","journal-title":"Clin Ther"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0235","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1517\/13543780902780175","article-title":"Review of rifaximin as treatment for SIBO and IBS","volume":"18","author":"Pimentel","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0240","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.13928","article-title":"Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth","volume":"45","author":"Gatta","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0245","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11894-015-0482-9","article-title":"How to test and treat small intestinal bacterial overgrowth: an evidence-based approach","volume":"18","author":"Rezaie","year":"2016","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0250","first-page":"4","article-title":"Microbiota intestinal y estre\u00f1imiento. Una puesta al d\u00eda","author":"Hanna-Jairala","year":"2021","journal-title":"NeuroGastroLATAM Reviews"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0255","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/apt.15099","article-title":"Systematic review with meta-analysis: the prevalence of bile acid malabsorption and response to colestyramine in patients with chronic watery diarrhoea and previous cholecystectomy","volume":"49","author":"Ruiz-Campos","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0260","article-title":"Real-world experience with the diagnosis of bile acid malabsorption (BAM) using serum 7-alpha-C4 and 48-hour stool bile acids","author":"Mendoza-Dom\u00ednguez","year":"2025","journal-title":"Rev Gastroenterol M\u00e9x"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0265","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1055\/a-1491-1784","article-title":"Effects of linaclotide in the treatment of chronic constipation and irritable bowel syndrome with constipation: a meta-analysis","volume":"60","author":"Zhao","year":"2022","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0270","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/apt.16437","article-title":"Systematic review and network meta-analysis: efficacy of licensed drugs for abdominal bloating in irritable bowel syndrome with constipation","volume":"54","author":"Nelson","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0275","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S2468-1253(19)30246-8","article-title":"Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis","volume":"4","author":"Luthra","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0280","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cpr.2016.11.001","article-title":"Comparative efficacy of psychological therapies for improving mental health and daily functioning in irritable bowel syndrome: A systematic review and meta-analysis","volume":"51","author":"Laird","year":"2017","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.rgmxen.2025.10.001_bib0285","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.3748\/wjg.v23.i12.2223","article-title":"Systematic review: The placebo effect of psychological interventions in the treatment of irritable bowel syndrome","volume":"23","author":"Flik","year":"2017","journal-title":"World J Gastroenterol"}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X25001215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X25001215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T21:42:32Z","timestamp":1764884552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2255534X25001215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2255534X25001215"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmxen.2025.10.001","relation":{},"ISSN":["2255-534X"],"issn-type":[{"type":"print","value":"2255-534X"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survey of Latin American gastroenterologists, specialists in disorders of gut-brain interaction, on the diagnosis and treatment of irritable bowel syndrome in clinical practice","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmxen.2025.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2025.03.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}